journal article·2020-06Open access

Spatiotemporal dual-delivery of therapeutic gas and growth factor for prevention of vascular stent thrombosis and restenosis

Qiufen Tu, Xin Zhao, Shuai Liu, Xiangyang Li, Qiang Zhang, Han Yu, Kaiqin Xiong, Nan Huang, Zhilu Yang

Abstract

Abstract Injury of endothelium is an inevitable consequence of cardiovascular stent implantation, which increases the incidence of in-stent restenosis (ISR) and late stent thrombosis (LST). Rapid and complete re-endothelialization, along with long-term suppression of smooth muscle cells (SMCs) are mandatory to alleviate these complications. To this goal, we designed a multi-functional stent coating, consisting of a vascular endothelial growth factor/CuII-dopamine(VEGF/CuII-DA) complex network for a spatiotemporal delivery of VEGF and nitric oxide (NO). We fabricated such network using a two-step stent-coating process: first a CuII-DA network with NO catalytic activity via metal-catecholamine coordination chemistry, followed by conjugation of VEGF onto the CuII-DA network via imine formation. The conjugated VEGF significantly accelerated the early-stage endothelial cell (EC) migration/growth for the first 7 days, forming a new and complete endothelial layer on the lumen. Furthermore, Cu ions sustainably decomposed endogenous S-nitrosothiols (RSNOs) in the bloodstream into NO for over 30 days, suppressing SMC migration/proliferation and ultimately preventing ISR and LST. Altogether, such designed stent coating provides options for a phase-adjusted endothelial repair during cardiovascular treatment.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nitric Oxide and Endothelin Effects · Coronary Interventions and Diagnostics · Intracranial Aneurysms: Treatment and Complications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors10.1161/CIRCRESAHA.117.308903 ↗
2. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors10.1111/jch.13195 ↗
3. The importance of the endothelium in atherothrombosis and coronary stenting10.1038/nrcardio.2012.64 ↗
4. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis10.1016/j.jacc.2015.04.017 ↗
5. Restenosis: delineating the numerous causes of drug-eluting stent restenosis10.1161/CIRCINTERVENTIONS.110.959882 ↗
6. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk10.1016/j.jacc.2006.03.042 ↗
7. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study10.1161/CIRCULATIONAHA.107.762047 ↗
8. Subacute stent thrombosis: evolving issues and current concepts10.1016/0735-1097(95)00466-1 ↗
9. Biological responses in stented arteries10.1093/cvr/cvt115 ↗
10. Inflammation and restenosis in the stent era10.1161/01.ATV.0000037100.44766.5B ↗
11. Stable titania nanostructures on stainless steel coronary stent surface for enhanced corrosion resistance and endothelialization10.1002/adhm.201601353 ↗
12. Biomimetic cardiovascular stents for in vivo re-endothelialization10.1016/j.biomaterials.2016.06.042 ↗
13. Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration10.1016/j.phrs.2014.12.003 ↗
14. Neointima formation after vascular stent implantation. Spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation10.1161/01.ATV.14.11.1846 ↗
15. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months10.1016/S0735-1097(00)01020-2 ↗
17. Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization10.1002/jbm.a.34714 ↗
18. Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation10.1016/j.biomaterials.2012.12.036 ↗
19. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
20. Nitric oxide releasing coronary stent: a new approach using layer-by-layer coating and liposomal encapsulation10.1002/smll.201600337 ↗
21. Lipid-based carriers for controlled delivery of nitric oxide10.1080/17425247.2017.1285904 ↗
22. Functional layer-by-layer thin films of inducible nitric oxide (NO) synthase oxygenase and polyethylenimine: modulation of enzyme loading and NO-release activity10.1021/acsami.7b17575 ↗
23. Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug10.1016/j.jconrel.2015.05.283 ↗
24. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model10.1038/gt.2011.92 ↗
25. Nitric oxide and atherosclerosis: an update10.1016/j.niox.2006.03.011 ↗
26. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents10.1016/j.biomaterials.2015.06.016 ↗
27. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents10.1016/j.biomaterials.2018.06.008 ↗
28. Mussel-inspired dopamine-CuII coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis10.1016/j.biomaterials.2018.12.020 ↗
29. Pathological correlates of late drug-eluting stent thrombosis10.1161/CIRCULATIONAHA.107.693739 ↗
30. Endothelial nitric oxide synthase in vascular disease: from marvel to menace10.1161/CIRCULATIONAHA.105.602532 ↗
31. A facile metal–phenolic–amine strategy for dual-functionalization of blood-contacting devices with antibacterial and anticoagulant properties10.1039/C8QM00458G ↗
32. Copper-induced vascular endothelial growth factor expression and wound healing10.1152/ajpheart.01015.2001 ↗
33. Mussel-inspired immobilization of vascular endothelial growth factor (VEGF) for enhanced endothelialization of vascular grafts10.1021/bm300194b ↗
34. The effect of VEGF functionalization of titanium on endothelial cells in vitro10.1016/j.biomaterials.2009.11.042 ↗
35. VEGF inhibits the inflammation in spinal cord injury through activation of autophagy10.1016/j.bbrc.2015.06.146 ↗
36. Development and application of metal materials in terms of vascular stents
37. Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering10.1016/j.biomaterials.2012.06.067 ↗
38. Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources10.1016/S1074-5521(96)90133-7 ↗
39. Copper-incorporated collagen/catechol film for in situ generation of nitric oxide10.1021/acsbiomaterials.5b00131 ↗
40. Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface10.1016/j.biomaterials.2011.08.018 ↗
41. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices10.1016/j.biomaterials.2012.07.050 ↗
42. Synergetic coordination and catecholamine chemistry for catalytic generation of nitric oxide on vascular stents10.1038/s41427-018-0052-3 ↗